NIH Locks Doors for Secret Grant Gossip on Brain Aging
Published Date: 5/4/2026
Notice
Summary
The NIH’s Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and decide on grant applications related to aging, genetics, neurodegeneration, and pediatric critical care. These meetings are private to protect sensitive information and personal privacy. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve new costs or changes to the process.
Analyzed Economic Effects
3 provisions identified: 3 benefits, 0 costs, 0 mixed.
Closed NIH grant review schedule
The NIH Center for Scientific Review will hold several closed virtual meetings between June 11 and June 18, 2026 to review grant applications in areas such as aging, genetics, neurodegeneration, pediatric critical care, cancer, and heart/lung training grants. If you are a researcher who applied for these grants, note these dates because they affect when funding decisions are made.
Protection of trade secrets and privacy
The meetings will be closed under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, commercial property (including patentable material), and personal information tied to grant applications. This closure is intended to prevent an unwarranted invasion of personal privacy and the disclosure of proprietary information from applicants.
No new costs or process changes
The notice states these meetings affect funding decisions but do not introduce new costs or change the grant review process. Applicants should expect the usual review procedures to be followed on the listed June 2026 dates.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
2026-14964, Center for Scientific Review; Notice of Closed Meeting
The Center for Scientific Review is holding a closed virtual meeting on August 19, 2026, to review neuroscience career development grant applications. This meeting is private to protect sensitive info like trade secrets and personal details. Researchers applying for these grants should note the date, as funding decisions could impact their projects and careers.
Previous / Next Documents
Previous: 2026-08604, Agency Information Collection Activities; Proposed Collection; Comment Request; National Youth Tobacco Survey
The FDA wants your thoughts on continuing the National Youth Tobacco Survey, which checks how many young people use tobacco. This survey helps protect kids and teens by tracking tobacco habits and making smarter health rules. If you want to share your opinion, send your comments by July 6, 2026—no cost to you, just your voice!
Next: 2026-08607, New Postal Products
The Postal Service wants to add or change some special mail deals that compete with other delivery options. This affects businesses and customers who use these competitive services, possibly changing prices or options soon. You’ve got until May 7, 2026, to share your thoughts before the Postal Regulatory Commission makes a decision.